JeniVision is an innovative biopharmaceutical company that strives to discover & develop advanced therapies for eye and skin diseases. With our creativity and ingenuity, we hope to create pathways in medicine for the future.
Jenny Wang, PhD, Chief Executive Officer, is an entrepreneur, an inventor, and a scientist. She leads and executes business plans for obtaining financing and establishing partnerships; leads and executes plans for pre-IND research & development, drug formulation, and IND filings. She co-led with the former CSO and now is leading the discovery, invention and intellectual property protection. She is well-trained in pharmacology, biochemistry, and molecular and cellular biology. Her therapeutic interests are ophthalmology, inflammation and hair growth, with > 40 peer reviewed scientific publications, >40 patents and over 25-year experience in pharmaceutical and biotechnology industry. She is the former Allergan Research Investigator and the team leader for hair growth research of the Latisse franchise.
Mrs. Nonna Snider, VP Clinical & Operations, joined JeniVision in March of 2020. She leads clinical research, manages FDA filing, and helps with company operation. She has over 20 years in pre-clinical and clinical drug development in both Pharmaceutical Industry and Academia. She has served as Assistant Director for Clinical Operations, responsible for ensuring safe and compliant implementation of Phase I, II and III oncology clinical trials conducted at the USC Norris Comprehensive Cancer Center, as well as basic researcher and Project Manager in pharmaceutical industry conducting pre-clinical and clinical research in US, India and Latin America, taking 1 Dermatology and 2 oncology compounds through pre-clinical and Phase I and II clinical trials. https://www.linkedin.com/in/nonna-snider-sheynkman-01b0084